Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127078741 | 12707874 | 1 | I | 20160129 | 20160321 | 20160901 | 20160901 | EXP | FR-PFIZER INC-3222611 | PFIZER | 49.00 | YR | F | Y | 61.00000 | KG | 20160901 | OT | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127078741 | 12707874 | 1 | PS | Carboplatine Hospira | CARBOPLATIN | 1 | UNK | Y | 76517 | SOLUTION FOR INJECTION | |||||||||
127078741 | 12707874 | 2 | SS | ALIMTA | PEMETREXED DISODIUM | 1 | 830 MG, UNK | Y | 0 | 830 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127078741 | 12707874 | 1 | Lung adenocarcinoma stage I |
127078741 | 12707874 | 2 | Lung adenocarcinoma stage I |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127078741 | 12707874 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127078741 | 12707874 | Cholestasis | |
127078741 | 12707874 | Disease progression | |
127078741 | 12707874 | Hepatocellular injury | |
127078741 | 12707874 | Lung adenocarcinoma stage I |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127078741 | 12707874 | 1 | 20160111 | 20160209 | 0 | |
127078741 | 12707874 | 2 | 20160111 | 20160209 | 0 |